COLLEGIUM PHARMACEUTICAL INC (COLL) competitors & alternatives
Health Care · NASDAQ
COLLEGIUM PHARMACEUTICAL INC (COLL)'s top competitors and alternatives — its most similar public companies — include INDIVIOR PHARMACEUTICALS INC (INDV), ETON PHARMACEUTCIALS INC (ETON), ADMA BIOLOGICS INC (ADMA), Jazz Pharmaceuticals (JAZZ), AQUESTIVE THERAPEUTICS INC (AQST), HERON THERAPEUTICS INC (HRTX), AVANOS MEDICAL INC (AVNS), SUPERNUS PHARMACEUTICALS INC (SUPN), ALKERMES (ALKS), PACIRA BIOSCIENCES INC (PCRX), Vertex Pharmaceuticals (VRTX) and TONIX PHARMACEUTICALS HOLDING CORP (TNXP). These are COLLEGIUM PHARMACEUTICAL INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top COLL competitors & alternatives
-
INDIVIOR PHARMACEUTICALS INCINDVHealth Care
Indivior is a specialty pharmaceutical company dedicated to developing and marketing treatments for substance use disorders and mental health conditions,…
$40.45 (as of 2026-07-22) · market cap $4.9B
-
ETON PHARMACEUTCIALS INCETONHealth Care
Eton Pharmaceuticals develops and commercializes rare disease treatments, with a portfolio of ten marketed products and four late-stage candidates targeting…
$43.58 (as of 2026-07-22) · market cap $1.2B
-
ADMA BIOLOGICS INCADMAHealth Care
ADMA manufactures and markets FDA-approved plasma-derived immune globulin products for immunodeficient and infectious disease patients, operating an integrated…
$8.38 (as of 2026-07-22) · market cap $2.0B
-
Jazz PharmaceuticalsJAZZHealth Care
A rare-disease biopharmaceutical company with diversified marketed therapies in epilepsy, sleep disorders, and oncology, and an expanding pipeline of…
$250.41 (as of 2026-07-22) · market cap $16.0B
-
AQUESTIVE THERAPEUTICS INCAQSTHealth Care
Aquestive develops orally disintegrating film formulations for CNS disorders, acute seizures, and opioid use, leveraging proprietary sublingual and buccal film…
$3.94 (as of 2026-07-22) · market cap $496M
-
HERON THERAPEUTICS INCHRTXHealth Care
A commercial-stage biotech company bringing specialized injectable medicines to acute care and oncology settings, with a focus on non-opioid pain management…
$0.47 (as of 2026-07-22) · market cap $90M
-
AVANOS MEDICAL INCAVNSHealth Care
Avanos Medical delivers non-opioid pain management and specialized nutrition feeding devices to hospitals and home care providers, reducing opioid dependency…
$24.98 (as of 2026-07-22) · market cap $1.2B
-
SUPERNUS PHARMACEUTICALS INCSUPNHealth Care
Supernus is a biopharmaceutical company commercializing approved CNS treatments across ADHD, Parkinson's disease, postpartum depression, epilepsy, and migraine…
$46.94 (as of 2026-07-22) · market cap $2.8B
-
ALKERMESALKSHealth Care
Alkermes is a neuroscience-focused biopharmaceutical company commercializing branded therapies for schizophrenia, bipolar disorder, narcolepsy, and substance…
$52.58 (as of 2026-07-22) · market cap $8.8B
-
PACIRA BIOSCIENCES INCPCRXHealth Care
Pacira BioSciences is a non-opioid pain management company commercializing injectable, device, and gene therapy treatments for postsurgical and osteoarthritis…
$25.59 (as of 2026-07-22) · market cap $1.0B
-
Vertex PharmaceuticalsVRTXHealth Care
Vertex Pharmaceuticals develops transformative medicines for serious genetic diseases, with a dominant pipeline anchored in cystic fibrosis treatments and…
$472.57 (as of 2026-07-22) · market cap $121.4B
-
TONIX PHARMACEUTICALS HOLDING CORPTNXPHealth Care
A fully-integrated biopharmaceutical company commercializing TONMYA (cyclobenzaprine sublingual tablets) for fibromyalgia while advancing a pipeline of CNS,…
$10.59 (as of 2026-07-22) · market cap $184M
Not quite? Describe exactly what you want →
Peers are COLLEGIUM PHARMACEUTICAL INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: COLLEGIUM PHARMACEUTICAL INC (COLL).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.